JW5-23667-86134
4 vaccinations
4 coded responses
33 check-ins
4 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 633 / MO
- Registered
- 2021-09-12
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-09-12
Registered in v-safe
-
2021-09-12
Dose 1 — Pfizer-BioNTech
- 2021-09-12
- 2021-09-13
- 2021-09-14
- 2021-09-15
- 2021-09-16
- 2021-09-17
- 2021-09-18
-
2021-09-26
Survey response — day 14, dose 1MedDRA: Nasal congestion, Oropharyngeal pain — Feeling: FairFree text: Nasal congestion, sore throatMedDRA releases: 2024-11 · check-in free text available
-
2021-10-03
Dose 2 — Pfizer-BioNTech
- 2021-10-03
-
2021-10-04
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-10-05
- 2021-10-06
- 2021-10-07
- 2021-10-08
- 2021-10-09
- 2021-10-10
- 2021-10-17
- 2021-10-24
- 2021-10-31
- 2021-11-07
- 2021-11-16
-
2022-01-04
Survey response — 3 months, dose 2MedDRA: Herpes simplex — Feeling: GoodFree text: HsvMedDRA releases: 2024-11 · check-in free text available
- 2022-04-03
-
2022-04-28
Dose 3 — Pfizer-BioNTech
- 2022-05-03
-
2022-05-05
Health check-in — day 7, dose 3Feeling: Poor · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
- 2022-05-12
- 2022-05-21
-
2022-05-26
Survey response — day 28, dose 3MedDRA: Cough, Oropharyngeal pain, Paranasal sinus discomfort, Respiratory tract congestion, Rhinorrhoea — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Sore throat, cough, runny nose, congestion, sinus pressureMedDRA releases: 2024-11 · check-in free text available
- 2022-06-02
- 2022-06-09
-
2022-07-28
Survey response — 3 months, dose 3MedDRA: Cough, Headache, Oropharyngeal pain, Pain — Feeling: Poor · Be unable to work or attend schoolFree text: Sore throat, cough, body aches, headachesMedDRA releases: 2024-11 · check-in free text available
-
2022-10-06
Dose 4 — Pfizer-BioNTechCo-administered: Flu
- 2022-10-27
- 2022-10-27
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-09-12 | Pfizer-BioNTech | No |
| 2 | 2021-10-03 | Pfizer-BioNTech | No |
| 3 | 2022-04-28 | Pfizer-BioNTech | No |
| 4 | 2022-10-06 | Pfizer-BioNTech | Flu |
Free text
Release 9 — day 14, dose 1
Symptoms: Nasal congestion, sore throat
Release 10 — 3 months, dose 2
Symptoms: Hsv
Release 11 — day 28, dose 3
Symptoms: Sore throat, cough, runny nose, congestion, sinus pressure
Release 12 — 3 months, dose 3
Symptoms: Sore throat, cough, body aches, headaches
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Herpes simplex | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Paranasal sinus discomfort | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release